AAAAAA
Results:
1-7
|
Results: 7
Authors:
VERGIN H
MAHR G
METZ R
EICHINGER A
NITSCHE V
Citation: H. Vergin et al., INVESTIGATION ON THE BIOEQUIVALENCE OF 2 ORAL PREPARATIONS CONTAININGSPIRONOLACTONE AND FUROSEMIDE, International journal of clinical pharmacology and therapeutics, 36(4), 1998, pp. 231-238
Authors:
NITSCHE V
OHLROGGE K
STURKEN K
Citation: V. Nitsche et al., REMOVAL OF ORGANIC VAPORS BY MEMBRANES, Chemieingenieurtechnik, 70(5), 1998, pp. 512-523
Authors:
VERGIN H
MAHR G
METZ R
EICHINGER A
NITSCHE V
MARTENS H
Citation: H. Vergin et al., ANALYSIS OF METABOLITES - A NEW APPROACH TO BIOEQUIVALENCE STUDIES OFSPIRONOLACTONE FORMULATIONS, International journal of clinical pharmacology and therapeutics, 35(8), 1997, pp. 334-340
Authors:
SCHUTZ H
EICHINGER A
NITSCHE V
HOFMANN R
Citation: H. Schutz et al., RELATIVE BIOAVAILABILITY OF 3 DIFFERENT CHLORMEZANONE 200-MG PREPARATIONS AFTER SINGLE-DOSE ORAL-ADMINISTRATION, International journal of clinical pharmacology and therapeutics, 35(3), 1997, pp. 112-116
Authors:
BOHNER H
JANIAK PS
NITSCHE V
EICHINGER A
SCHUTZ H
Citation: H. Bohner et al., RELATIVE BIOAVAILABILITY OF DIFFERENT BUTAMIRATE CITRATE PREPARATIONSAFTER SINGLE-DOSE ORAL-ADMINISTRATION TO 18 HEALTHY-VOLUNTEERS, International journal of clinical pharmacology and therapeutics, 35(3), 1997, pp. 117-122
Authors:
DOSER K
GUSERLE R
NITSCHE V
ARNOLD G
Citation: K. Doser et al., COMPARATIVE STEADY-STATE STUDY WITH 2 FENOFIBRATE 250-MG SLOW-RELEASECAPSULES - AN EXAMPLE OF BIOEQUIVALENCE ASSESSMENT WITH A HIGHLY VARIABLE DRUG, International journal of clinical pharmacology and therapeutics, 34(8), 1996, pp. 345-348
Authors:
DOSER K
MEYER B
NITSCHE V
BINKERTGRABER P
Citation: K. Doser et al., BIOEQUIVALENCE EVALUATION OF 2 DIFFERENT ORAL FORMULATIONS OF LOPERAMIDE (DIAREX-LACTAB VS IMODIUM CAPSULES), International journal of clinical pharmacology and therapeutics, 33(8), 1995, pp. 431-436
Risultati:
1-7
|